Molecular Cancer

official impact factor 3.78
Search for
Advanced search
Molecular Cancer
Tools
Share this article
Open Access

Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy?

Carlos Perez-Plasencia and Alfonso Duenas-Gonzalez*

Molecular Cancer 2006, 5:27 doi:10.1186/1476-4598-5-27

Accesses  

  • Last 30 days: 83 accesses
  • Last 365 days: 958 accesses
  • All time: 6313 accesses

Cited by

BioMed Central: 1 citation

Research   Open Access Highly Accessed

Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine

Blanca Segura-Pacheco, Enrique Perez-Cardenas, Lucia Taja-Chayeb, Alma Chavez-Blanco, Alma Revilla-Vazquez, Luis Benitez-Bribiesca, Alfonso Duenas-González Journal of Translational Medicine 2006, 4:32 (7 August 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations